🇺🇸 FDA
Pipeline program

Methylprednisolone and Mycophenolate mofetil

OS-2

Approved small_molecule active

Quick answer

Methylprednisolone and Mycophenolate mofetil for Autoimmune Hepatitis is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Autoimmune Hepatitis
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials